Barclays analyst Benjamin Theurer upgraded Bunge (BG) to Overweight from Equal Weight with a price target of $120, up from $105. The firm says dilution from the Viterra merger is less than feared. Barclays is now confident in Bunge’s ability to drive better mid-cycle earnings. It sees the stock outperforming peers in 2026 amid additional vertical integration benefits.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: